Stay updated on AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial

Sign up to get notified when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    An NIH-wide notice about terminology changes appears above the 403 error page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:34:22.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:42:27.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The study record page is currently returning a 403 Forbidden error, blocking access to the study details and related information on the page. Users cannot view documents, locations, or other study data.
    Difference
    18%
    Check dated 2026-09-23T01:02:28.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, indicating a new release of the page or its underlying tooling. This update does not alter the visible study details.
    Difference
    0.0%
    Check dated 2026-09-15T23:57:48.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    A new investigator/location entry Tel Litwinsky, Israel was added, along with a new publication citation related to ATTR-CM attributes. A location entry Qiryat Krinitzi, Israel was removed.
    Difference
    0.1%
    Check dated 2026-09-08T22:30:04.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Qiryat Krinitzi, Israel was added to the study sites and Tel Litwinsky, Israel was removed. The page revision was updated to v3.6.6.
    Difference
    0.1%
    Check dated 2026-09-01T20:21:56.000Z thumbnail image

Stay in the know with updates to AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.